Left Atrial Structure and Function, Clinical Outcomes, and Efficacy of Vutrisiran in Transthyretin Amyloidosis With Cardiomyopathy: A Secondary Analysis of the HELIOS-B Randomized Clinical Trial.
- DOI
- 10.1001/jamacardio.2026.2992
- Published
- 2026 Aug 19
- Container
- JAMA cardiology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1001/jamacardio.2026.2992,
title = {Left Atrial Structure and Function, Clinical Outcomes, and Efficacy of Vutrisiran in Transthyretin Amyloidosis With Cardiomyopathy: A Secondary Analysis of the HELIOS-B Randomized Clinical Trial.},
author = {Jering KS and Manafi A and Claggett BL and Bart NK and Prasad N and Birkhoelzer SM and Hamatani Y and Lairez O and Tsujita K and Gillmore JD and Maurer MS and Jay PY and Skali H and Fontana M and Solomon SD},
year = {2026},
journal = {JAMA cardiology},
doi = {10.1001/jamacardio.2026.2992},
url = {https://doi.org/10.1001/jamacardio.2026.2992}
}RIS
TY - JOUR TI - Left Atrial Structure and Function, Clinical Outcomes, and Efficacy of Vutrisiran in Transthyretin Amyloidosis With Cardiomyopathy: A Secondary Analysis of the HELIOS-B Randomized Clinical Trial. AU - Jering KS AU - Manafi A AU - Claggett BL AU - Bart NK AU - Prasad N AU - Birkhoelzer SM AU - Hamatani Y AU - Lairez O AU - Tsujita K AU - Gillmore JD AU - Maurer MS AU - Jay PY AU - Skali H AU - Fontana M AU - Solomon SD PY - 2026 JO - JAMA cardiology DO - 10.1001/jamacardio.2026.2992 UR - https://doi.org/10.1001/jamacardio.2026.2992 ER -
APA
KS, J., A, M., BL, C., NK, B., N, P., SM, B., Y, H., O, L., K, T., JD, G., MS, M., PY, J., H, S., M, F., & SD, S. (2026). Left Atrial Structure and Function, Clinical Outcomes, and Efficacy of Vutrisiran in Transthyretin Amyloidosis With Cardiomyopathy: A Secondary Analysis of the HELIOS-B Randomized Clinical Trial.. JAMA cardiology. https://doi.org/10.1001/jamacardio.2026.2992
Source records
- pubmed · retrieved 2026-09-25T12:40:33.199Z